KalVista Pharmaceuticals (KALV)

[Femto99]

I would not even buy the shares at $20.

[Femto99]

All in puts!

[Stock_Barber]

Boom!

Killed it with puts today!

[ClayTrader]

* * $KALV Video Chart 02-09-2021 * *

Link to Video - click here to watch the technical chart video

[Stock_Barber]

This company is a disaster...

[make it happen]

The company is delinquent.

[make it happen]

? lol

Profitability
Profit Margin 0.00%
Gross Profit (ttm) $-27.5M
EBITDA $-48.38M
Net Income Avi to Common (ttm) $-37.12M
Diluted EPS (ttm) -2.08

Book Value Per Share (mrq) $3.63

Going to keep diluting more and more

[make it happen]

They are hemorrhaging money. Have pretty much zero revenue. They still have hundreds of millions to spend of your money until phase 3 and beyond.

Operating Margin (ttm) -905.50%

Management Effectiveness

Return on Assets (ttm) -32.60%
Return on Equity (ttm) -45.61%

Revenue  $5.4M
Revenue Per Share  $0.30

[TFMG]

$KALV Kalvista Pharma Trend Break



Major Downtrend broken
Broken above 200ma
Volume increased
MACD reversed
RSi in bullish uptrend

[whytestocks]

News: $KALV KalVista Pharmaceuticals Appoints Daniel B. Soland to Board of Directors

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, announced today that Daniel Soland has been appointed to its Board of Directors effective immediately. Mr...

Find out more https://marketwirenews.com/news-releases/kalvista-pharmaceuticals-appoints-daniel-b-soland-to-board-of-directors-8035190.html

[whytestocks]

News: $KALV KalVista Pharmaceuticals to Present at Needham Healthcare Conference

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, today announced that it will present at the Needham Healthcare Conference on Wednesday, April 10, 2019, a...

Read the whole news https://marketwirenews.com/news-releases/kalvista-pharmaceuticals-to-present-at-needham-healthcare-conference-7939130.html

[stocktrademan]

KALV buy 28.87



normal chart







log chart

[whytestocks]

News: $KALV KalVista Pharmaceuticals Reports Fiscal Third Quarter Results

– Oral Hereditary Angioedema (HAE) Candidate KVD900 Phase 2 Trial Progressing – – Intravitreal Diabetic Macular Edema (DME) Candidate KVD001 Phase 2 Trial Completion Expected H2 2019 – – Oral Plasma Kallikrein Inhibitor Candidate KVD824 Dosi...

Read the whole news https://marketwirenews.com/news-releases/kalvista-pharmaceuticals-reports-fiscal-third-quarter-results-7846828.html

[countryrapper2000]

Where is everyone?

[TheFinalCD]

$17.85 !!


KALV

[Lone Wolf]

Sniffer rocket ship today!! Wheeee.

KALV

[TheFinalCD]

$15.50 now ~ keep rollin



$KALV

[kondziu]

http://m.nasdaq.com/article/sv-life-sciences-advisers-llc-buys-kalvista-pharmaceuticals-sells-raptor-pharmaceutical-cm744623

[Warchest]

$8.25 now ~ keep rollin

[ming1234]

any positive news and volume will move this north

[Warchest]

LIVE action starting !!!

[Warchest]

watching close ~

[Toxic Avenger]

The way this is dropping, there has to be a lawsuit over the sale of cash at 60% off.
Where are those ambulance chasing securities lawyers?

[MSparks6]

So when will CBYL holders be issued KALV common stock?

[Toxic Avenger]

CBYL is now KALV with a 1:14 reverse stock split.

Be very careful for the next few days as until all or most of the CBYL shares are converted to KALV, the only sellers will be private Kal Vista investors, those who bought after the symbol change and professionals. The price is likely to be high until existing CBYL retail holders can sell their shares. In addition, the existing CBYL shares will only represent 20% of the O/S. 80% will be held by the private investors in KVAL.

[Iam_in]

$6.00

[Iam_in]

New Ticker symbol now: KALV

[Iam_in]

Correction : $5.49 PM

[Iam_in]

WOW - look at this $0,89---> $4,60

New Ticker name now : KALV

look at NASDAQ - PM

[Toxic Avenger]

Apparently the merger deal was approved by a huge margin.

Still don't get it.

[ClayTrader]

* * $CBYL Video Chart 11-21-16 * *

Link to Video - click here to watch the technical chart video

[beginneer]

Attempting to break 0.72. GL to holders

[beginneer]

We'll see how this goes. Hopefully back to over a dollar.

[Toxic Avenger]

CBYL continuing its upward momentum pre-market.

[ClayTrader]

* * $CBYL Video Chart 11-18-16 * *

Link to Video - click here to watch the technical chart video

[beginneer]

Oh okay. Im still up for it even if it is a merger. Good thing volume picked up today.

[Toxic Avenger]

New buyer? They're not being bought, they're merging with another company and selling their cash at a steep discount.

Maybe the large shareholders decided it's better to take a smaller loss now by liquidating, than wait for a larger loss later and they're voting against the deal.

I can only hope!

[beginneer]

Somethings fishy going on here. Why the sudden spike in volume? New buyer in sight?

[Toxic Avenger]

Fun while it lasted.

[Toxic Avenger]

Big bounce today. Anyone know why?

[Toxic Avenger]

$700k / month for a company that has only a few execs and no business left???

No wonder they want to merge. If they liquidate, the execs all lose their gravy train.

Maybe that can be part of the class action suit.

[Toxic Avenger]

Looks like an attempt to prevent the merger by some shareholders has failed. http://ih.advfn.com/p.php?pid=nmona&article=72839538&symbol=CBYL

[Toxic Avenger]

Looks like an attempt to prevent the merger by some shareholders has failed. http://ih.advfn.com/p.php?pid=nmona&article=72839538&symbol=CBYL

[Toxic Avenger]

Sadly, I don't think so.

[MSparks6]

Any idea what the general consensus among shareholders is? We gonna be able to block this merger or is a 'no' vote futile?

[Value_Investor]

LOL, CBYL declined back to $0.49 again! The next two supports are $0.4505 and $0.4401.

Let' see if that very sick merger deal still goes through...

Anyway the planned big Reverse/Split (1:14) should kick in very soon unless we all vote against it!

[Value_Investor]

Can you please stick that post#376 to the CBYL board? Thanks in advance! We all should call the company and let them merge with TNXP to protect our interests in CBYL! It will be the best deal for both Debt-Free and High BV & CV Bio-Tech NASDAQ companies!

Anyway CBYL is up 5.6% so far! $0.4984 seems the New bottom support! Hopefully it will test last week's highs area $0.544 ~ $0.54 again before the end of today...

Now CBYL has Three strong supporting price $0.4401, $0.4505, and $0.475!

Who are those very stupid sellers which put 88K shares at $0.60 and over 130K shares at $0.65?

[Toxic Avenger]

Get him on the phone NOW!

[Value_Investor]

A New Merger proposal to the CEO of CBYL! TNXP is the best merger candidate for CBYL since both companies have Zero-Debt and High Positive Book Value & Cash Value plus TNXP has two FDA-Approved New Drugs (Phase3 and Phase2 respectively)! It is called "Stronger Together Merger"...

In this way the combined company will have very strong cash flow and very strong financial strength without any debt at all plus the two very promised New drugs with FDA-Approval!

Should this deal kick in both public stocks will be doubled within a single day! This is the best solution for both companies and their shareholders! TNXP may take 70% ownership v.s. CBYL take the rest 30% ownership...

[Value_Investor]

CBYL declined to $0.4984 so far from yesterday's high $0.545! Let's see if the price will test $0.475 or even $0.4505 again during the rest of today...

I wish $0.46 ~ $0.47 could hold the New bottom support for this round of price correction so that CBYL can easily test $0.57 ~ $0.545 again!

Anyway the 52-week low is $0.4401 which was created a couple of weeks ago without any bad news at all except the terrible aged reverse-merger deal --- see the link below for the details.

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11616426